Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Spirometer Market, by Product Type (Hand Held, Table Top, and Desktop), by Technology Type (Volume Measurement, Flow Measurement, and Peak Flow Measurement), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Pulmonary Fibrosis, and Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)), by End User (Hospitals and Clinics, and Home Healthcare), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 958.0  million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.

For instance, in April 2017, Monitored Therapeutics, Inc., a U.S. based healthcare company received the U.S. Food and Drug Administration approval for its newly developed product GoSpiro which is a spirometer indicated for real time measurement of lung air flow and volume enabled with on screen visualization. GoSpiro can be used at clinical as well as homecare setting.

Global Spirometer Market – Impact of Coronavirus (Covid-19) Pandemic

COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 197 million cases and 4.2 million deaths due to Coronavirus (COVID-19) were reported up till August 6, 2021, across the globe.

The COVID-19 pandemic has negatively affected several markets across the globe but is expected to fuel the demand and supply in global spirometer market owing to potential use of spirometer for treatment of mild to moderate COVID-19 infection during the COVID-19 outbreak.

For instance, in June 2021, Tidal Medical Technologies, a U.S. based healthcare company received emergency use authorization from the U.S. FDA for its InSee incentive spirometer accessory which can be used alongside AirLife incentive spirometer, manufactured by Vyaire Medical, Inc., a U.S. based healthcare company. InSee incentive spirometer accessory can be used to track the usage of AirLife incentive spirometer in patients suffering from COVID-19.

Browse 38 Market Data Tables and 28 Figures spread through 165 Pages and in-depth TOC on “Spirometer Market”- Global Forecast to 2028, by Product Type (Hand Held, Table Top, and Desktop), by Technology Type (Volume Measurement, Flow Measurement, and Peak Flow Measurement), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Pulmonary Fibrosis, and Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)), by End User (Hospitals and Clinics, and Home Healthcare), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global spirometer market, click the link below:

https://www.coherentmarketinsights.com/market-insight/spirometer-market-2615

Key players operating in the market are focusing on adoption of inorganic growth strategies such as collaborations and acquisitions, in order to strengthen their position in the market. For instance, in June 2020, MGC Diagnostics Corporation, a U.S. based diagnostic company entered into a distributive partnership with Monitored Therapeutics, Inc. in order to expand its respiratory care product portfolio by distributing GoSpiro, a spirometer manufactured by Monitored Therapeutics, Inc.

Key Takeaways of the Global Spirometer Market:

  • The global spirometer market is expected to exhibit a CAGR of 9.5% over the forecast period, owing to growing number of product launches and regulatory approvals. For instance, in August 2020, Vitalograph, a U.S. based respiratory diagnostics company received the U.S. FDA 510(k) clearance for its newly developed handheld spirometer named as In2itive e-Diary.
  • Among application, chronic obstructive pulmonary disease segment is expected to account for the largest market share during the forecast period, owing to growing prevalence of chronic obstructive pulmonary disease. For instance, according to an article published in the European Respiratory Journal in 2019, the worldwide mean prevalence of chronic obstructive pulmonary disease was estimated to be around 13.1% in 2019 which is an increase as compared to 11.7% in 2010.
  • Key players operating in the global spirometer market include Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.